Iris Verel Selected Research

Antibodies

1/2016	A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.
5/2002	Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iris Verel Research Topics

Disease

7	Neoplasms (Cancer) 01/2016 - 05/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 12/2004 - 05/2002
2	Squamous Cell Carcinoma of Head and Neck 08/2003 - 05/2002
1	Disease Progression 01/2016
1	Breast Neoplasms (Breast Cancer) 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2004

Drug/Important Bio-Agent (IBA)

4	(124)I-cMAb U36IBA 12/2004 - 08/2003
3	Monoclonal AntibodiesIBA 04/2004 - 05/2002
2	AntibodiesIBA 01/2016 - 05/2002
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2003 - 08/2003
2	AntigensIBA 10/2003 - 05/2002
1	Galectin 1 (LGALS1)IBA 01/2016
1	Galectins (Galectin)IBA 01/2016
1	FibrinIBA 06/2015
1	N-succinyldesferrioxamine BIBA 10/2003
1	AcidsIBA 10/2003
1	Immunoconjugates (Immunoconjugate)IBA 08/2003
1	Hepatitis B e AntigensIBA 05/2002
1	EpitopesIBA 05/2002

Therapy/Procedure

3	Radioimmunotherapy 01/2005 - 08/2003